Study suggests inhaled technosphere insulin could be considered as an option for adults ...
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
Healio2 天
Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes
Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...
EurekAlert!4 天
Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 ...
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...
Nature17 年
Pfizer dumps Exubera
After 11 years of development and barely one full year of sales, New York–based Pfizer dumped the much-anticipated inhaled powder insulin product Exubera on 18 October. This was particularly bad ...
Medindia1 年
Inhaled Insulin To Be Made Available in India
The world's largest drug maker, Pfizer has announced that it intends to fast track its inhaled insulin Exubera in India. The world's largest drug maker, Pfizer has announced that it intends to ...
Nasdaq13 天
MannKind Corporation Showcases Positive Outcomes of Inhaled Insulin at ATTD 2025 with ...
MannKind Corporation announced that it will present data from five studies on inhaled insulin at the 18th International Conference on Advanced Technologies and Treatments for Diabetes in Amsterdam ...
pharmaphorum7 年
Dance Biopharm to develop inhaled insulin with Phillips-Medisize
US biotech Dance Biopharm is to work with Phillips-Medisize, to develop a version of its inhaled insulin device that has data connectivity for better management of diabetes treatment. Inhaled ...